Do Recovery Supplements Actually Work?

We pull every credible human trial and mechanistic study behind the five most-marketed recovery supplements and score each one honestly - separating plausible biochemical rationale from evidence-free marketing claims.

Walk through any festival supplement aisle or scroll through the party-recovery corner of the internet and you will meet the same five ingredients again and again: magnesium, 5-HTP, alpha-lipoic acid (ALA), EGCG (green tea extract), and vitamin C. The pitch is consistent: take these before, during, and after you roll, and you will clench less, crash softer, and protect your brain. The pitch is also mostly unexamined. Below we grade each one on two separate questions - is there a plausible biochemical reason it might help, and is there actual human evidence that it does. Those are not the same question, and conflating them is exactly how weak claims get sold as strong ones.

Magnesium: for jaw clenching (mixed, mostly indirect)

The rationale is the most concrete of the bunch. MDMA drives bruxism - the involuntary jaw clenching and grinding that leaves people sore the next day. Magnesium is involved in normal muscle relaxation and neuromuscular signalling, so the idea that supplementing it might reduce clenching is at least mechanistically coherent.

The problem is the evidence gap. There is no controlled trial testing magnesium against MDMA-induced bruxism specifically. What exists is indirect: magnesium has been studied for sleep-related bruxism and general muscle cramp with underwhelming and inconsistent results, and those populations are not people on MDMA.

• Plausibility: reasonable.
• Human evidence for the specific claim: essentially none.
• Honest grade: mixed to weak. Many people report subjectively less clenching, but that is anecdote, and chewing gum does a similar job for the jaw itself.

Magnesium is generally well tolerated, with loose stools being the main nuisance at higher doses. So the harm ceiling is low, but so is the demonstrated benefit.

5-HTP: the one with the biggest safety asterisk

5-HTP is a direct precursor to serotonin. MDMA works by flooding and then depleting serotonin, and the low mood in the days after ("Tuesday blues") is widely attributed to that depletion. On paper, giving the body raw material to rebuild serotonin sounds elegant.

Here is where mechanism and safety collide. Taking a serotonin precursor while MDMA is still active - or while its effects are still winding down - raises the theoretical risk of pushing serotonin too high, which is the mechanism behind serotonin syndrome. This is why the more cautious harm-reduction convention is to wait until MDMA has cleared before taking 5-HTP, not to co-dose it. For exactly when each of these belongs - before, during, the night of, and after - see the MDMA supplement stack timeline.

Even setting timing aside, there is no robust human trial showing that post-MDMA 5-HTP actually improves the comedown. The serotonin-depletion story itself is a simplification of a more complicated recovery process.

• Plausibility: high in theory.
• Human evidence for the specific claim: none of quality.
• Honest grade: emerging at best, and the safety caveat outweighs the thin upside.

Alpha-lipoic acid: neuroprotection built on animal data

ALA is an antioxidant, and the neuroprotection pitch rests on a specific worry: that MDMA generates oxidative stress and reactive oxygen species that may contribute to serotonergic damage in heavy or hot conditions. Antioxidants, the argument goes, could mop those up.

The supporting studies are almost entirely in rats, using doses and administration routes that do not map cleanly onto a human taking a capsule with a festival dose. Animal antioxidant studies with MDMA have shown some protective signals, but "protective in a rodent model" is a long way from "prevents harm in a human."

• Plausibility: moderate, resting on a real oxidative-stress mechanism.
• Human evidence for the specific claim: none.
• Honest grade: animal-only. Treat any neuroprotection claim as unproven in people.

EGCG: the same story, greener

EGCG, the main catechin in green tea extract, gets marketed on two claims: antioxidant neuroprotection (same logic as ALA) and a more interesting one - that it may inhibit some of the enzymes involved in metabolising MDMA into potentially neurotoxic byproducts.

Both are drawn from cell and animal work. The enzyme-interaction angle is genuinely intriguing mechanistically, but it also cuts the other way: anything that alters how you metabolise MDMA could in principle change blood levels and effects unpredictably, and none of that has been characterised in humans taking MDMA.

• Plausibility: moderate and mechanistically specific.
• Human evidence for the specific claim: none.
• Honest grade: animal-only, with an added note that "it changes MDMA metabolism" is not automatically a good thing.

Vitamin C: the weakest case of the five

Vitamin C is the most heavily marketed and the least defensible. It is a water-soluble antioxidant, and the entire pitch is a generic version of the oxidative-stress argument. There is no MDMA-specific human trial, and even the mechanistic rationale is weaker than ALA's or EGCG's because vitamin C is a fairly blunt, non-targeted antioxidant.

• Plausibility: low to moderate, entirely generic.
• Human evidence for the specific claim: none.
• Honest grade: evidence-free for the specific claim. It is cheap and safe, which is likely why it appears everywhere, but cheap and safe is not the same as effective.

The honest scorecard

Line them up and a pattern appears. Every one of these has a story you can tell on a whiteboard, and not one has a decent human trial testing whether it does what it is sold to do for MDMA specifically.

• Magnesium: best case for a real, if minor, benefit (clenching) - still not directly trialled.
• 5-HTP: most plausible mechanism, biggest safety asterisk, no quality human data.
• ALA and EGCG: mechanistically interesting, animal-only, unproven in people.
• Vitamin C: the most marketed, the least supported.

The credibility gap here is not subtle. Products and posts routinely present mechanistic plausibility as if it were proof of effect. It is not. When you see any of these recommended, the useful question is always the same: is there a human trial, in people using MDMA, measuring the outcome being claimed? For all five, the current answer is no or barely.

If you are managing a comedown, the boring interventions with the strongest support - sleep, hydration without overdoing water, food, rest, and time - remain unglamorous and largely unbeatable.

Sources

• https://ravedoctor.com/blog
• https://partydoctor.cz/blog

Browse all guides →